Search Results - Jonathan L. Wright
- Showing 1 - 9 results of 9
-
1
-
2
-
3
-
4
-
5
Patterns of chemotherapy use with primary radiotherapy for localized bladder cancer in patients 65 or older by Fady Ghali, Sarah K. Holt, Elizabeth L. Koehne, Jonathan J. Chen, Emily S. Weg, Jay J. Liao, Jing Zeng, Petros Grivas, Petros Grivas, Jessica E. Hawley, Jessica E. Hawley, Andrew C. Hsieh, Andrew C. Hsieh, Robert Bruce Montgomery, Robert Bruce Montgomery, Jonathan L. Wright, Jonathan L. Wright
Published in Frontiers in Oncology (2024-05-01)Get full text
Article -
6
Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer by Franklin C. Lee, William Harris, Heather H. Cheng, Jaideep Shenoi, Song Zhao, Junfeng Wang, Thomas Champion, Jason Izard, John L. Gore, Michael Porter, Evan Y. Yu, Jonathan L. Wright
Published in Advances in Urology (2013-01-01)Get full text
Article -
7
Application of Health Technology Assessment (HTA) to Evaluate New Laboratory Tests in a Health System: A Case Study of Bladder Cancer Testing by Erik J. Landaas MPH, Ashley M. Eckel MD, PhD, Jonathan L. Wright MD, Geoffrey S. Baird MD, PhD, Ryan N. Hansen PhD, PharmD, Sean D. Sullivan PhD
Published in Academic Pathology (2020-11-01)Get full text
Article -
8
Pharmacological NF‐κB inhibition decreases cisplatin chemoresistance in muscle‐invasive bladder cancer and reduces cisplatin‐induced toxicities. by Rui M. Gil da Costa, Christine Levesque, Daniella Bianchi‐Frias, Payel Chatterjee, Hung‐Ming Lam, Carlos Santos, Ilsa M. Coleman, Pedro Ferreirinha, Manuel Vilanova, Nazaré Pinto da Cunha, Hugo Carvalho, Alexandra Moreira‐Pais, Ana Faustino‐Rocha, Tiago Neto, José Batista da Costa, Jonathan L. Wright, Rita Ferreira, Paula A. Oliveira, Joaquim Mendes, Margarida M. S. M. Bastos, Bruno Colaço, Carlos Lopes, Peter C. Black, Christopher J. Sweeney, Peter S. Nelson
Published in Molecular Oncology (2023-12-01)Get full text
Article -
9
Perioperative Blood Transfusion Is Associated with Worse Survival in Patients Undergoing Radical Cystectomy after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer by Tessa Ladner, Anna J. Black, Homayoun Zargar, Jonathan L. Wright, Andrew C. Thorpe, Todd M. Morgan, Jeff M. Holzbeierlein, Michael S. Cookson, Niels-Erik Jacobsen, Adrian S. Fairey, Colin P. N. Dinney, Maria C. Mir, Laura-Maria Krabbe, Jeffrey S. Montgomery, Nikhil Vasdev, Evan Y. Yu, Evanguelos Xylinas, Andrew J. Stephenson, Jay B. Shah, Siamak Daneshmand, Kamran Zargar-Shoshtari, Philippe E. Spiess, Laura S. Mertens, Bas W. G. van Rhijn, Petros Grivas, Wassim Kassouf, Marc A. Dall’Era, Srikala S. Sridhar, Jonathan S. McGrath, Jonathan Aning, Shahrokh F. Shariat, Trinity J. Bivalacqua, Scott A. North, Daniel A. Barocas, Yair Lotan, Peter C. Black
Published in Société Internationale d’Urologie Journal (2024-06-01)Get full text
Article
